Stimcell Energetics (STME) Return on Capital Employed (2017 - 2019)
Stimcell Energetics' (STME) quarterly Return on Capital Employed came in at 6.18% in Q1 2019, down 125.35% quarter-over-quarter from 24.39% in Q4 2018.
Stimcell Energetics (STME) Return on Capital Employed (2017 - 2019) Analysis & Trends
Stimcell Energetics' Return on Capital Employed history runs 3 years deep, the most recent figure standing at 6.18% for Q1 2019.
- On a quarterly basis, Return on Capital Employed changed N/A year-over-year to 6.18% in Q1 2019; TTM through Feb 2019 was 6.18%, a N/A change from a year earlier, with the FY2017 full-year figure at 103.27%, down 3280.0% from the prior year.
- Return on Capital Employed fell to 6.18% in Q1 2019 per STME's latest filing, from 24.39% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 106.24% in Q2 2017 and bottomed at 6.18% in Q1 2019.
- The 3-year median for Return on Capital Employed is 39.56% (2018), against an average of 44.8%.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2019 | -6.18% |
| Nov 30, 2018 | 24.39% |
| Aug 31, 2018 | 54.74% |
| May 31, 2017 | 106.24% |